During the past decade, Sverdlovsk Regional Oncology Dispensary; Chemotherapy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sverdlovsk Regional Oncology Dispensary; Chemotherapy" are "Carcinoma, Transitional Cell" (1 trials) and "Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)" (1 trials). Many other conditions were trialed in "Sverdlovsk Regional Oncology Dispensary; Chemotherapy" in a lesser frequency.

Most popular intervention types in "Sverdlovsk Regional Oncology Dispensary; Chemotherapy" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sverdlovsk Regional Oncology Dispensary; Chemotherapy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sverdlovsk Regional Oncology Dispensary; Chemotherapy". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sverdlovsk Regional Oncology Dispensary; Chemotherapy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sverdlovsk Regional Oncology Dispensary; Chemotherapy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".